Fig. 3: Chromatin accesibility may explain the deregulation of genes.
From: Drug repositioning for immunotherapy in breast cancer using single-cell analysis
An illustration of crhomatin accisibility using ATAC-seq data for four distinct breast cancer (BC) cell lines including two triple-negative breast cancer (TNBC) cell lines (MDA-MB-231 and MDA-MB-436) with repetitions27, one estrogen receptor-positive BC cell line (MCF7) with repetitions28 and two normal MCF-10A breast epithelial cell lines29,30.
